1h Free Analyst Time
Speak directly to the analyst to clarify any post sales queries you may have.
The MHC-peptide complex market is undergoing rapid transformation, driven by scientific advances and shifting global supply chains. Senior decision-makers require precise market intelligence to capitalize on innovation, navigate emerging risks, and maintain competitive advantage in this evolving sector.
Market Snapshot: Navigating the MHC-Peptide Complex Market
The major histocompatibility complex (MHC)-peptide complex market stands at the intersection of immunology, diagnostics, and biologics. Recent years have seen a surge in assay innovation, advanced recombinant technologies, and integrated platforms. Demand is expanding across therapeutic, diagnostic, and research domains. Strategic investments, regional manufacturing, and regulatory adjustments are influencing product lifecycles and supply chain strategies, creating opportunities and constraining certain procurement timelines for stakeholders worldwide. Incorporating empowered regional hubs and adaptive business models, this ecosystem attracts pharmaceutical, diagnostics, and biotech firms seeking high-value, customized assay solutions.
Scope & Segmentation of the MHC-Peptide Complex Market
This comprehensive report provides detailed coverage and actionable insights into all key segments, regions, and technologies that define today’s MHC-peptide complex landscape.
- Product Types: Kits & reagents (including detection and labeling kits), recombinant and soluble MHC molecules, epitope peptides, and modified peptides.
- Applications: Diagnostics targeting autoimmune disease, cancer, and infectious disease; research use in basic and translational studies; and therapeutic uses in immunotherapy and vaccine development.
- End Users: Academic and research institutes, contract research organizations, hospitals, diagnostic laboratories, pharmaceutical, and biotech companies.
- Technologies: ELISA formats (competitive and sandwich), flow cytometry (imaging and multicolor), and mass spectrometry platforms (LC-MS, MALDI-TOF).
- MHC Classes: Classical and non-classical Class I, Class II (HLA-DP, HLA-DQ, HLA-DR), and non-classical variants.
- Regions: Americas (United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including Germany, United Kingdom, France, Russia, UAE, Saudi Arabia, South Africa), and Asia-Pacific (China, India, Japan, Australia, and key Southeast Asian markets).
- Companies Profiled: Thermo Fisher Scientific Inc., Merck KGaA, Danaher Corporation, Becton Dickinson and Company, Roche Holding AG, Bio-Techne Corporation, Abcam plc, Enzo Biochem Inc.
MHC-Peptide Complex Market: Key Takeaways for Senior Decision-Makers
- Technological evolution is fueling a shift from basic reagents toward fully integrated assay solutions, enabling higher specificity and deeper immune profiling.
- Artificial intelligence adoption in peptide prediction and the proliferation of single-cell analysis techniques are changing competitive positioning among providers.
- Customizable portfolios are increasingly demanded, reflecting end-user requirements for alignment with diverse therapeutic targets and regulatory frameworks.
- Strategic alliances and regional capacity building, especially in less trade-impacted areas, are mitigating supply interruptions and fostering knowledge transfer.
- Regulatory harmonization and early engagement are reducing approval friction for market entrants while ensuring ongoing product quality.
Tariff Impact: Strategic Responses to 2025 U.S. Adjustments
The 2025 introduction of updated United States tariff structures is driving realignment in sourcing models and supplier diversification across the MHC-peptide market. Faced with new import duties on essential components, organizations are accelerating domestic production, regionalizing supply, and establishing strategic cross-border alliances. These maneuvers ensure continued access to critical reagents and maintain innovation momentum amid a changing cost environment. Procurement cycles are adapting, underscoring the strategic value of agile logistics and flexible contracts.
Methodology & Data Sources
Our market analysis employs a blend of primary and secondary research, including expert interviews, user surveys, regulatory reviews, published literature, and triangulation of proprietary supplier data. Rigorous peer reviews and consistency checks ensure that every finding in this report is robust, accurate, and actionable.
Why This Report Matters: Decision-Ready Insights for Executives
- Enables precise market entry and product strategy to address complex end-user requirements and regulatory variation.
- Equips leadership teams to respond proactively to external challenges such as tariff changes or supply chain disruptions.
- Delivers a holistic perspective across technology, regional dynamics, and strategic partnerships, supporting forward-looking planning and investment.
Conclusion
The MHC-peptide complex market rewards agile strategies, technological foresight, and informed collaboration. This report ensures access to reliable intelligence, empowering senior leaders to drive growth and enduring value in a dynamic sector.
This product will be delivered within 1-3 business days.
Table of Contents
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Increasing adoption of AI-driven epitope prediction algorithms for high-throughput MHC-peptide binding analysis
5.2. Emergence of neoantigen-based personalized cancer vaccines spurring demand for tailored MHC-peptide formulations
5.3. Innovations in multivalent nanoparticle delivery systems enhancing antigen presentation via MHC-peptide complexes
5.4. Integration of single-cell multiomics platforms to profile MHC-peptide repertoire dynamics in immunotherapy research
5.5. Shift towards universal MHC-binding synthetic peptides to streamline vaccine development workflows
5.6. Expansion of multiplexed mass spectrometry techniques for high-resolution mapping of MHC-bound peptide epitopes
5.7. Increasing focus on class II MHC-peptide modulation for autoimmune disease therapeutic development
5.8. Growth of cloud-based bioinformatics pipelines for real-time MHC-peptide interaction modeling and data sharing
5.9. Adoption of in vitro cell-free MHC loading assays accelerating screening of peptide candidates for T cell activation
5.2. Emergence of neoantigen-based personalized cancer vaccines spurring demand for tailored MHC-peptide formulations
5.3. Innovations in multivalent nanoparticle delivery systems enhancing antigen presentation via MHC-peptide complexes
5.4. Integration of single-cell multiomics platforms to profile MHC-peptide repertoire dynamics in immunotherapy research
5.5. Shift towards universal MHC-binding synthetic peptides to streamline vaccine development workflows
5.6. Expansion of multiplexed mass spectrometry techniques for high-resolution mapping of MHC-bound peptide epitopes
5.7. Increasing focus on class II MHC-peptide modulation for autoimmune disease therapeutic development
5.8. Growth of cloud-based bioinformatics pipelines for real-time MHC-peptide interaction modeling and data sharing
5.9. Adoption of in vitro cell-free MHC loading assays accelerating screening of peptide candidates for T cell activation
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
6.2. PESTLE Analysis
8. MHC-peptide Complexes Market, by Product Type
8.1. Introduction
8.2. Kits & Reagents
8.2.1. Detection Kits
8.2.2. Labeling Kits
8.3. MHC Molecules
8.3.1. Recombinant MHC
8.3.2. Soluble MHC
8.4. Peptides
8.4.1. Epitope Peptides
8.4.2. Modified Peptides
8.2. Kits & Reagents
8.2.1. Detection Kits
8.2.2. Labeling Kits
8.3. MHC Molecules
8.3.1. Recombinant MHC
8.3.2. Soluble MHC
8.4. Peptides
8.4.1. Epitope Peptides
8.4.2. Modified Peptides
9. MHC-peptide Complexes Market, by Application
9.1. Introduction
9.2. Diagnostic
9.2.1. Autoimmune Disease
9.2.2. Cancer Diagnostics
9.2.3. Infectious Disease
9.3. Research Use
9.3.1. Basic Research
9.3.2. Translational Research
9.4. Therapeutic
9.4.1. Immunotherapy
9.4.2. Vaccine Development
9.2. Diagnostic
9.2.1. Autoimmune Disease
9.2.2. Cancer Diagnostics
9.2.3. Infectious Disease
9.3. Research Use
9.3.1. Basic Research
9.3.2. Translational Research
9.4. Therapeutic
9.4.1. Immunotherapy
9.4.2. Vaccine Development
10. MHC-peptide Complexes Market, by End User
10.1. Introduction
10.2. Academic and Research Institutes
10.3. Contract Research Organizations
10.4. Hospitals and Diagnostic Laboratories
10.5. Pharmaceutical Biotech Companies
10.2. Academic and Research Institutes
10.3. Contract Research Organizations
10.4. Hospitals and Diagnostic Laboratories
10.5. Pharmaceutical Biotech Companies
11. MHC-peptide Complexes Market, by Technology
11.1. Introduction
11.2. ELISA
11.2.1. Competitive ELISA
11.2.2. Sandwich ELISA
11.3. Flow Cytometry
11.3.1. Imaging Cytometry
11.3.2. Multicolor Cytometry
11.4. Mass Spectrometry
11.4.1. LC-MS
11.4.2. MALDI-TOF
11.2. ELISA
11.2.1. Competitive ELISA
11.2.2. Sandwich ELISA
11.3. Flow Cytometry
11.3.1. Imaging Cytometry
11.3.2. Multicolor Cytometry
11.4. Mass Spectrometry
11.4.1. LC-MS
11.4.2. MALDI-TOF
12. MHC-peptide Complexes Market, by MHC Class
12.1. Introduction
12.2. Class I
12.2.1. Classical Class I
12.2.2. Non-Classical Class I
12.3. Class II
12.3.1. HLA-DP
12.3.2. HLA-DQ
12.3.3. HLA-DR
12.4. Non-Classical
12.2. Class I
12.2.1. Classical Class I
12.2.2. Non-Classical Class I
12.3. Class II
12.3.1. HLA-DP
12.3.2. HLA-DQ
12.3.3. HLA-DR
12.4. Non-Classical
13. Americas MHC-peptide Complexes Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa MHC-peptide Complexes Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific MHC-peptide Complexes Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Thermo Fisher Scientific Inc.
16.3.2. Merck KGaA
16.3.3. Danaher Corporation
16.3.4. Becton Dickinson and Company
16.3.5. Roche Holding AG
16.3.6. Bio-Techne Corporation
16.3.7. Abcam plc
16.3.8. Enzo Biochem, Inc.
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Thermo Fisher Scientific Inc.
16.3.2. Merck KGaA
16.3.3. Danaher Corporation
16.3.4. Becton Dickinson and Company
16.3.5. Roche Holding AG
16.3.6. Bio-Techne Corporation
16.3.7. Abcam plc
16.3.8. Enzo Biochem, Inc.
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. MHC-PEPTIDE COMPLEXES MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 12. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY MHC CLASS, 2024 VS 2030 (%)
FIGURE 14. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY MHC CLASS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS MHC-PEPTIDE COMPLEXES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS MHC-PEPTIDE COMPLEXES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES MHC-PEPTIDE COMPLEXES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES MHC-PEPTIDE COMPLEXES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC MHC-PEPTIDE COMPLEXES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC MHC-PEPTIDE COMPLEXES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. MHC-PEPTIDE COMPLEXES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. MHC-PEPTIDE COMPLEXES MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. MHC-PEPTIDE COMPLEXES MARKET: RESEARCHAI
FIGURE 26. MHC-PEPTIDE COMPLEXES MARKET: RESEARCHSTATISTICS
FIGURE 27. MHC-PEPTIDE COMPLEXES MARKET: RESEARCHCONTACTS
FIGURE 28. MHC-PEPTIDE COMPLEXES MARKET: RESEARCHARTICLES
FIGURE 2. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 12. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY MHC CLASS, 2024 VS 2030 (%)
FIGURE 14. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY MHC CLASS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS MHC-PEPTIDE COMPLEXES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS MHC-PEPTIDE COMPLEXES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES MHC-PEPTIDE COMPLEXES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES MHC-PEPTIDE COMPLEXES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC MHC-PEPTIDE COMPLEXES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC MHC-PEPTIDE COMPLEXES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. MHC-PEPTIDE COMPLEXES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. MHC-PEPTIDE COMPLEXES MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. MHC-PEPTIDE COMPLEXES MARKET: RESEARCHAI
FIGURE 26. MHC-PEPTIDE COMPLEXES MARKET: RESEARCHSTATISTICS
FIGURE 27. MHC-PEPTIDE COMPLEXES MARKET: RESEARCHCONTACTS
FIGURE 28. MHC-PEPTIDE COMPLEXES MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. MHC-PEPTIDE COMPLEXES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY KITS & REAGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY KITS & REAGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY DETECTION KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY DETECTION KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY LABELING KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY LABELING KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY KITS & REAGENTS, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY KITS & REAGENTS, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY MHC MOLECULES, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY MHC MOLECULES, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY RECOMBINANT MHC, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY RECOMBINANT MHC, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY SOLUBLE MHC, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY SOLUBLE MHC, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY MHC MOLECULES, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY MHC MOLECULES, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY PEPTIDES, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY PEPTIDES, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY EPITOPE PEPTIDES, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY EPITOPE PEPTIDES, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY MODIFIED PEPTIDES, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY MODIFIED PEPTIDES, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY PEPTIDES, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY PEPTIDES, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY DIAGNOSTIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY DIAGNOSTIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY AUTOIMMUNE DISEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY AUTOIMMUNE DISEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY CANCER DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY CANCER DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY INFECTIOUS DISEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY INFECTIOUS DISEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY DIAGNOSTIC, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY DIAGNOSTIC, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY RESEARCH USE, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY RESEARCH USE, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY BASIC RESEARCH, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY BASIC RESEARCH, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY TRANSLATIONAL RESEARCH, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY TRANSLATIONAL RESEARCH, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY RESEARCH USE, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY RESEARCH USE, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY THERAPEUTIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY THERAPEUTIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY IMMUNOTHERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY IMMUNOTHERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY VACCINE DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY VACCINE DEVELOPMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY THERAPEUTIC, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY THERAPEUTIC, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY HOSPITALS AND DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY HOSPITALS AND DIAGNOSTIC LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY PHARMACEUTICAL BIOTECH COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY PHARMACEUTICAL BIOTECH COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY ELISA, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY ELISA, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY COMPETITIVE ELISA, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY COMPETITIVE ELISA, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY SANDWICH ELISA, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY SANDWICH ELISA, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY ELISA, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY ELISA, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY IMAGING CYTOMETRY, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY IMAGING CYTOMETRY, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY MULTICOLOR CYTOMETRY, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY MULTICOLOR CYTOMETRY, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY FLOW CYTOMETRY, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY FLOW CYTOMETRY, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY LC-MS, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY LC-MS, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY MALDI-TOF, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY MALDI-TOF, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY MASS SPECTROMETRY, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY MHC CLASS, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY MHC CLASS, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY CLASS I, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY CLASS I, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY CLASSICAL CLASS I, BY REGION, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY CLASSICAL CLASS I, BY REGION, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY NON-CLASSICAL CLASS I, BY REGION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY NON-CLASSICAL CLASS I, BY REGION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY CLASS I, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY CLASS I, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY CLASS II, BY REGION, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY CLASS II, BY REGION, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY HLA-DP, BY REGION, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY HLA-DP, BY REGION, 2025-2030 (USD MILLION)
TABLE 113. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY HLA-DQ, BY REGION, 2018-2024 (USD MILLION)
TABLE 114. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY HLA-DQ, BY REGION, 2025-2030 (USD MILLION)
TABLE 115. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY HLA-DR, BY REGION, 2018-2024 (USD MILLION)
TABLE 116. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY HLA-DR, BY REGION, 2025-2030 (USD MILLION)
TABLE 117. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY CLASS II, 2018-2024 (USD MILLION)
TABLE 118. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY CLASS II, 2025-2030 (USD MILLION)
TABLE 119. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY NON-CLASSICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 120. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY NON-CLASSICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 121. AMERICAS MHC-PEPTIDE COMPLEXES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 122. AMERICAS MHC-PEPTIDE COMPLEXES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 123. AMERICAS MHC-PEPTIDE COMPLEXES MARKET SIZE, BY KITS & REAGENTS, 2018-2024 (USD MILLION)
TABLE 124. AMERICAS MHC-PEPTIDE COMPLEXES MARKET SIZE, BY KITS & REAGENTS, 2025-2030 (USD MILLION)
TABLE 125. AMERICAS MHC-PEPTIDE COMPLEXES MARKET SIZE, BY MHC MOLECULES, 2018-2024 (USD MILLION)
TABLE 126. AMERICAS MHC-PEPTIDE COMPLEXES MARKET SIZE, BY MHC MOLECULES, 2025-2030 (USD MILLION)
TABLE 127. AMERICAS MHC-PEPTIDE COMPLEXES MARKET SIZE, BY PEPTIDES, 2018-2024 (USD MILLION)
TABLE 128. AMERICAS MHC-PEPTIDE COMPLEXES MARKET SIZE, BY PEPTIDES, 2025-2030 (USD MILLION)
TABLE 129. AMERICAS MHC-PEPTIDE COMPLEXES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 130. AMERICAS MHC-PEPTIDE COMPLEXES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 131. AMERICAS MHC-PEPTIDE COMPLEXES MARKET SIZE, BY DIAGNOSTIC, 2018-2024 (USD MILLION)
TABLE 132. AMERICAS MHC-PEPTIDE COMPLEXES MARKET SIZE, BY DIAGNOSTIC, 2025-2030 (USD MILLION)
TABLE 133. AMERICAS MHC-PEPTIDE COMPLEXES MARKET SIZE, BY RESEARCH USE, 2018-2024 (USD MILLION)
TABLE 134. AMERICAS MHC-PEPTIDE COMPLEXES MARKET SIZE, BY RESEARCH USE, 2025-2030 (USD MILLION)
TABLE 135. AMERICAS MHC-PEPTIDE COMPLEXES MARKET SIZE, BY THERAPEUTIC, 2018-2024 (USD MILLION)
TABLE 136. AMERICAS MHC-PEPTIDE COMPLEXES MARKET SIZE, BY THERAPEUTIC, 2025-2030 (USD MILLION)
TABLE 137. AMERICAS MHC-PEPTIDE COMPLEXES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 138. AMERICAS MHC-PEPTIDE COMPLEXES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 139. AMERICAS MHC-PEPTIDE COMPLEXES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 140. AMERICAS MHC-PEPTIDE COMPLEXES MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 141. AMERICAS MHC-PEPTIDE COMPLEXES MARKET SIZE, BY ELISA, 2018-2024 (USD MILLION)
TABLE 142. AMERICAS MHC-PEPTIDE COMPLEXES MARKET SIZE, BY ELISA, 2025-2030 (USD MILLION)
TABLE 143. AMERICAS MHC-PEPTIDE COMPLEXES MARKET SIZE, BY FLOW CYTOMETRY, 2018-2024 (USD MILLION)
TABLE 144. AMERICAS MHC-PEPTIDE COMPLEXES MARKET SIZE, BY FLOW CYTOMETRY, 2025-2030 (USD MILLION)
TABLE 145. AMERICAS MHC-PEPTIDE COMPLEXES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2024 (USD MILLION)
TABLE 146. AMERICAS MHC-PEPTIDE COMPLEXES MARKET SIZE, BY MASS SPECTROMETRY, 2025-2030 (USD MILLION)
TABLE 147. AMERICAS MHC-PEPTIDE COMPLEXES MARKET SIZE, BY MHC CLASS, 2018-2024 (USD MILLION)
TABLE 148. AMERICAS MHC-PEPTIDE COMPLEXES MARKET SIZE, BY MHC CLASS, 2025-2030 (USD MILLION)
TABLE 149. AMERICAS MHC-PEPTIDE COMPLEXES MARKET SIZE, BY CLASS I, 2018-2024 (USD MILLION)
TABLE 150. AMERICAS MHC-PEPTIDE COMPLEXES MARKET SIZE, BY CLASS I, 2025-2030 (USD MILLION)
TABLE 151. AMERICAS MHC-PEPTIDE COMPLEXES MARKET SIZE, BY CLASS II, 2018-2024 (USD MILLION)
TABLE 152. AMERICAS MHC-PEPTIDE COMPLEXES MARKET SIZE, BY CLASS II, 2025-2030 (USD MILLION)
TABLE 153. AMERICAS MHC-PEPTIDE COMPLEXES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 154. AMERICAS MHC-PEPTIDE COMPLEXES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 155. UNITED STATES MHC-PEPTIDE COMPLEXES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 156. UNITED STATES MHC-PEPTIDE COMPLEXES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 157. UNITED STATES MHC-PEPTIDE COMPLEXES MARKET SIZE, BY KITS & REAGENTS, 2018-2024 (USD MILLION)
TABLE 158. UNITED STATES MHC-PEPTIDE COMPLEXES MARKET SIZE, BY KITS & REAGENTS, 2025-2030 (USD MILLION)
TABLE 159. UNITED STATES MHC-PEPTIDE COMPLEXES MARKET SIZE, BY MHC MOLECULES, 2018-2024 (USD MILLION)
TABLE 160. UNITED STATES MHC-PEPTIDE COMPLEXES MARKET SIZE, BY MHC MOLECULES, 2025-2030 (USD MILLION)
TABLE 161. UNITED STATES MHC-PEPTIDE COMPLEXES MARKET SIZE, BY PEPTIDES, 2018-2024 (USD MILLION)
TABLE 162. UNITED STATES MHC-PEPTIDE COMPLEXES MARKET SIZE, BY PEPTIDES, 2025-2030 (USD MILLION)
TABLE 163. UNITED STATES MHC-PEPTIDE COMPLEXES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 164. UNITED STATES MHC-PEPTIDE COMPLEXES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 165. UNITED STATES MHC-PEPTIDE COMPLEXES MARKET SIZE, BY DIAGNOSTIC, 2018-2024 (USD MILLION)
TABLE 166. UNITED STATES MHC-PEPTIDE COMPLEXES MARKET SIZE, BY DIAGNOSTIC, 2025-2030 (USD MILLION)
TABLE 167. UNITED STATES MHC-PEPTIDE COMPLEXES MARKET SIZE, BY RESEARCH USE, 2018-2024 (USD MILLION)
TABLE 168. UNITED STATES MHC-PEPTIDE COMPLEXES MARKET SIZE, BY RESEARCH USE, 2025-2030 (USD MILLION)
TABLE 169. UNITED STATES MHC-PEPTIDE COMPLEXES MARKET SIZE, BY THERAPEUTIC, 2018-2024 (USD MILLION)
TABLE 170. UNITED STATES MHC-PEPTIDE COMPLEXES MARKET SIZE, BY THERAPEUTIC, 2025-2030 (USD MILLION)
TABLE 171. UNITED STATES MHC-PEPTIDE COMPLEXES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 172. UNITED STATES MHC-PEPTIDE COMPLEXES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 173. UNITED STATES MHC-PEPTIDE COMPLEXES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 174. UNITED STATES MHC-PEPTIDE COMPLEXES MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 175. UNITED STATES MHC-PEPTIDE COMPLEXES MARKET SIZE, BY ELISA, 2018-2024 (USD MILLION)
TABLE 176. UNITED STATES MHC-PEPTIDE COMPLEXES MARKET SIZE, BY ELISA, 2025-2030 (USD MILLION)
TABLE 177. UNITED STATES MHC-PEPTIDE COMPLEXES MARKET SIZE, BY FLOW CYTOMETRY, 2018-2024 (USD MILLION)
TABLE 178. UNITED STATES MHC-PEPTIDE COMPLEXES MARKET SIZE, BY FLOW CYTOMETRY, 2025-2030 (USD MILLION)
TABLE 179. UNITED STATES MHC-PEPTIDE COMPLEXES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2024 (USD MILLION)
TABLE 180. UNITED STATES MHC-PEPTIDE COMPLEXES MARKET SIZE, BY MASS SPECTROMETRY, 2025-2030 (USD MILLION)
TABLE 181. UNITED STATES MHC-PEPTIDE COMPLEXES MARKET SIZE, BY MHC CLASS, 2018-2024 (USD MILLION)
TABLE 182. UNITED STATES MHC-PEPTIDE COMPLEXES MARKET SIZE, BY MHC CLASS, 2025-2030 (USD MILLION)
TABLE 183. UNITED STATES MHC-PEPTIDE COMPLEXES MARKET SIZE, BY CLASS I, 2018-2024 (USD MILLION)
TABLE 184. UNITED STATES MHC-PEPTIDE COMPLEXES MARKET SIZE, BY CLASS I, 2025-2030 (USD MILLION)
TABLE 185. UNITED STATES MHC-PEPTIDE COMPLEXES MARKET SIZE, BY CLASS II, 2018-2024 (USD MILLION)
TABLE 186. UNITED STATES MHC-PEPTIDE COMPLEXES MARKET SIZE, BY CLASS II, 2025-2030 (USD MILLION)
TABLE 187. UNITED STATES MHC-PEPTIDE COMPLEXES MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 188. UNITED STATES MHC-PEPTIDE COMPLEXES MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 189. CANADA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 190. CANADA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 191. CANADA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY KITS & REAGENTS, 2018-2024 (USD MILLION)
TABLE 192. CANADA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY KITS & REAGENTS, 2025-2030 (USD MILLION)
TABLE 193. CANADA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY MHC MOLECULES, 2018-2024 (USD MILLION)
TABLE 194. CANADA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY MHC MOLECULES, 2025-2030 (USD MILLION)
TABLE 195. CANADA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY PEPTIDES, 2018-2024 (USD MILLION)
TABLE 196. CANADA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY PEPTIDES, 2025-2030 (USD MILLION)
TABLE 197. CANADA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 198. CANADA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 199. CANADA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY DIAGNOSTIC, 2018-2024 (USD MILLION)
TABLE 200. CANADA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY DIAGNOSTIC, 2025-2030 (USD MILLION)
TABLE 201. CANADA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY RESEARCH USE, 2018-2024 (USD MILLION)
TABLE 202. CANADA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY RESEARCH USE, 2025-2030 (USD MILLION)
TABLE 203. CANADA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY THERAPEUTIC, 2018-2024 (USD MILLION)
TABLE 204. CANADA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY THERAPEUTIC, 2025-2030 (USD MILLION)
TABLE 205. CANADA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 206. CANADA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 207. CANADA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 208. CANADA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 209. CANADA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY ELISA, 2018-2024 (USD MILLION)
TABLE 210. CANADA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY ELISA, 2025-2030 (USD MILLION)
TABLE 211. CANADA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY FLOW CYTOMETRY, 2018-2024 (USD MILLION)
TABLE 212. CANADA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY FLOW CYTOMETRY, 2025-2030 (USD MILLION)
TABLE 213. CANADA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2024 (USD MILLION)
TABLE 214. CANADA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY MASS SPECTROMETRY, 2025-2030 (USD MILLION)
TABLE 215. CANADA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY MHC CLASS, 2018-2024 (USD MILLION)
TABLE 216. CANADA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY MHC CLASS, 2025-2030 (USD MILLION)
TABLE 217. CANADA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY CLASS I, 2018-2024 (USD MILLION)
TABLE 218. CANADA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY CLASS I, 2025-2030 (USD MILLION)
TABLE 219. CANADA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY CLASS II, 2018-2024 (USD MILLION)
TABLE 220. CANADA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY CLASS II, 2025-2030 (USD MILLION)
TABLE 221. MEXICO MHC-PEPTIDE COMPLEXES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 222. MEXICO MHC-PEPTIDE COMPLEXES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 223. MEXICO MHC-PEPTIDE COMPLEXES MARKET SIZE, BY KITS & REAGENTS, 2018-2024 (USD MILLION)
TABLE 224. MEXICO MHC-PEPTIDE COMPLEXES MARKET SIZE, BY KITS & REAGENTS, 2025-2030 (USD MILLION)
TABLE 225. MEXICO MHC-PEPTIDE COMPLEXES MARKET SIZE, BY MHC MOLECULES, 2018-2024 (USD MILLION)
TABLE 226. MEXICO MHC-PEPTIDE COMPLEXES MARKET SIZE, BY MHC MOLECULES, 2025-2030 (USD MILLION)
TABLE 227. MEXICO MHC-PEPTIDE COMPLEXES MARKET SIZE, BY PEPTIDES, 2018-2024 (USD MILLION)
TABLE 228. MEXICO MHC-PEPTIDE COMPLEXES MARKET SIZE, BY PEPTIDES, 2025-2030 (USD MILLION)
TABLE 229. MEXICO MHC-PEPTIDE COMPLEXES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 230. MEXICO MHC-PEPTIDE COMPLEXES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 231. MEXICO MHC-PEPTIDE COMPLEXES MARKET SIZE, BY DIAGNOSTIC, 2018-2024 (USD MILLION)
TABLE 232. MEXICO MHC-PEPTIDE COMPLEXES MARKET SIZE, BY DIAGNOSTIC, 2025-2030 (USD MILLION)
TABLE 233. MEXICO MHC-PEPTIDE COMPLEXES MARKET SIZE, BY RESEARCH USE, 2018-2024 (USD MILLION)
TABLE 234. MEXICO MHC-PEPTIDE COMPLEXES MARKET SIZE, BY RESEARCH USE, 2025-2030 (USD MILLION)
TABLE 235. MEXICO MHC-PEPTIDE COMPLEXES MARKET SIZE, BY THERAPEUTIC, 2018-2024 (USD MILLION)
TABLE 236. MEXICO MHC-PEPTIDE COMPLEXES MARKET SIZE, BY THERAPEUTIC, 2025-2030 (USD MILLION)
TABLE 237. MEXICO MHC-PEPTIDE COMPLEXES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 238. MEXICO MHC-PEPTIDE COMPLEXES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 239. MEXICO MHC-PEPTIDE COMPLEXES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 240. MEXICO MHC-PEPTIDE COMPLEXES MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 241. MEXICO MHC-PEPTIDE COMPLEXES MARKET SIZE, BY ELISA, 2018-2024 (USD MILLION)
TABLE 242. MEXICO MHC-PEPTIDE COMPLEXES MARKET SIZE, BY ELISA, 2025-2030 (USD MILLION)
TABLE 243. MEXICO MHC-PEPTIDE COMPLEXES MARKET SIZE, BY FLOW CYTOMETRY, 2018-2024 (USD MILLION)
TABLE 244. MEXICO MHC-PEPTIDE COMPLEXES MARKET SIZE, BY FLOW CYTOMETRY, 2025-2030 (USD MILLION)
TABLE 245. MEXICO MHC-PEPTIDE COMPLEXES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2024 (USD MILLION)
TABLE 246. MEXICO MHC-PEPTIDE COMPLEXES MARKET SIZE, BY MASS SPECTROMETRY, 2025-2030 (USD MILLION)
TABLE 247. MEXICO MHC-PEPTIDE COMPLEXES MARKET SIZE, BY MHC CLASS, 2018-2024 (USD MILLION)
TABLE 248. MEXICO MHC-PEPTIDE COMPLEXES MARKET SIZE, BY MHC CLASS, 2025-2030 (USD MILLION)
TABLE 249. MEXICO MHC-PEPTIDE COMPLEXES MARKET SIZE, BY CLASS I, 2018-2024 (USD MILLION)
TABLE 250. MEXICO MHC-PEPTIDE COMPLEXES MARKET SIZE, BY CLASS I, 2025-2030 (USD MILLION)
TABLE 251. MEXICO MHC-PEPTIDE COMPLEXES MARKET SIZE, BY CLASS II, 2018-2024 (USD MILLION)
TABLE 252. MEXICO MHC-PEPTIDE COMPLEXES MARKET SIZE, BY CLASS II, 2025-2030 (USD MILLION)
TABLE 253. BRAZIL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 254. BRAZIL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 255. BRAZIL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY KITS & REAGENTS, 2018-2024 (USD MILLION)
TABLE 256. BRAZIL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY KITS & REAGENTS, 2025-2030 (USD MILLION)
TABLE 257. BRAZIL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY MHC MOLECULES, 2018-2024 (USD MILLION)
TABLE 258. BRAZIL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY MHC MOLECULES, 2025-2030 (USD MILLION)
TABLE 259. BRAZIL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY PEPTIDES, 2018-2024 (USD MILLION)
TABLE 260. BRAZIL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY PEPTIDES, 2025-2030 (USD MILLION)
TABLE 261. BRAZIL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 262. BRAZIL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 263. BRAZIL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY DIAGNOSTIC, 2018-2024 (USD MILLION)
TABLE 264. BRAZIL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY DIAGNOSTIC, 2025-2030 (USD MILLION)
TABLE 265. BRAZIL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY RESEARCH USE, 2018-2024 (USD MILLION)
TABLE 266. BRAZIL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY RESEARCH USE, 2025-2030 (USD MILLION)
TABLE 267. BRAZIL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY THERAPEUTIC, 2018-2024 (USD MILLION)
TABLE 268. BRAZIL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY THERAPEUTIC, 2025-2030 (USD MILLION)
TABLE 269. BRAZIL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 270. BRAZIL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 271. BRAZIL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 272. BRAZIL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 273. BRAZIL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY ELISA, 2018-2024 (USD MILLION)
TABLE 274. BRAZIL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY ELISA, 2025-2030 (USD MILLION)
TABLE 275. BRAZIL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY FLOW CYTOMETRY, 2018-2024 (USD MILLION)
TABLE 276. BRAZIL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY FLOW CYTOMETRY, 2025-2030 (USD MILLION)
TABLE 277. BRAZIL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2024 (USD MILLION)
TABLE 278. BRAZIL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY MASS SPECTROMETRY, 2025-2030 (USD MILLION)
TABLE 279. BRAZIL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY MHC CLASS, 2018-2024 (USD MILLION)
TABLE 280. BRAZIL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY MHC CLASS, 2025-2030 (USD MILLION)
TABLE 281. BRAZIL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY CLASS I, 2018-2024 (USD MILLION)
TABLE 282. BRAZIL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY CLASS I, 2025-2030 (USD MILLION)
TABLE 283. BRAZIL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY CLASS II, 2018-2024 (USD MILLION)
TABLE 284. BRAZIL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY CLASS II, 2025-2030 (USD MILLION)
TABLE 285. ARGENTINA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 286. ARGENTINA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 287. ARGENTINA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY KITS & REAGENTS, 2018-2024 (USD MILLION)
TABLE 288. ARGENTINA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY KITS & REAGENTS, 2025-2030 (USD MILLION)
TABLE 289. ARGENTINA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY MHC MOLECULES, 2018-2024 (USD MILLION)
TABLE 290. ARGENTINA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY MHC MOLECULES, 2025-2030 (USD MILLION)
TABLE 291. ARGENTINA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY PEPTIDES, 2018-2024 (USD MILLION)
TABLE 292. ARGENTINA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY PEPTIDES, 2025-2030 (USD MILLION)
TABLE 293. ARGENTINA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 294. ARGENTINA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 295. ARGENTINA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY DIAGNOSTIC, 2018-2024 (USD MILLION)
TABLE 296. ARGENTINA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY DIAGNOSTIC, 2025-2030 (USD MILLION)
TABLE 297. ARGENTINA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY RESEARCH USE, 2018-2024 (USD MILLION)
TABLE 298. ARGENTINA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY RESEARCH USE, 2025-2030 (USD MILLION)
TABLE 299. ARGENTINA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY THERAPEUTIC, 2018-2024 (USD MILLION)
TABLE 300. ARGENTINA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY THERAPEUTIC, 2025-2030 (USD MILLION)
TABLE 301. ARGENTINA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 302. ARGENTINA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 303. ARGENTINA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 304. ARGENTINA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 305. ARGENTINA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY ELISA, 2018-2024 (USD MILLION)
TABLE 306. ARGENTINA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY ELISA, 2025-2030 (USD MILLION)
TABLE 307. ARGENTINA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY FLOW CYTOMETRY, 2018-2024 (USD MILLION)
TABLE 308. ARGENTINA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY FLOW CYTOMETRY, 2025-2030 (USD MILLION)
TABLE 309. ARGENTINA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2024 (USD MILLION)
TABLE 310. ARGENTINA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY MASS SPECTROMETRY, 2025-2030 (USD MILLION)
TABLE 311. ARGENTINA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY MHC CLASS, 2018-2024 (USD MILLION)
TABLE 312. ARGENTINA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY MHC CLASS, 2025-2030 (USD MILLION)
TABLE 313. ARGENTINA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY CLASS I, 2018-2024 (USD MILLION)
TABLE 314. ARGENTINA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY CLASS I, 2025-2030 (USD MILLION)
TABLE 315. ARGENTINA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY CLASS II, 2018-2024 (USD MILLION)
TABLE 316. ARGENTINA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY CLASS II, 2025-2030 (USD MILLION)
TABLE 317. EUROPE, MIDDLE EAST & AFRICA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 318. EUROPE, MIDDLE EAST & AFRICA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 319. EUROPE, MIDDLE EAST & AFRICA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY KITS & REAGENTS, 2018-2024 (USD MILLION)
TABLE 320. EUROPE, MIDDLE EAST & AFRICA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY KITS & REAGENTS, 2025-2030 (USD MILLION)
TABLE 321. EUROPE, MIDDLE EAST & AFRICA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY MHC MOLECULES, 2018-2024 (USD MILLION)
TABLE 322. EUROPE, MIDDLE EAST & AFRICA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY MHC MOLECULES, 2025-2030 (USD MILLION)
TABLE 323. EUROPE, MIDDLE EAST & AFRICA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY PEPTIDES, 2018-2024 (USD MILLION)
TABLE 324. EUROPE, MIDDLE EAST & AFRICA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY PEPTIDES, 2025-2030 (USD MILLION)
TABLE 325. EUROPE, MIDDLE EAST & AFRICA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 326. EUROPE, MIDDLE EAST & AFRICA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 327. EUROPE, MIDDLE EAST & AFRICA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY DIAGNOSTIC, 2018-2024 (USD MILLION)
TABLE 328. EUROPE, MIDDLE EAST & AFRICA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY DIAGNOSTIC, 2025-2030 (USD MILLION)
TABLE 329. EUROPE, MIDDLE EAST & AFRICA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY RESEARCH USE, 2018-2024 (USD MILLION)
TABLE 330. EUROPE, MIDDLE EAST & AFRICA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY RESEARCH USE, 2025-2030 (USD MILLION)
TABLE 331. EUROPE, MIDDLE EAST & AFRICA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY THERAPEUTIC, 2018-2024 (USD MILLION)
TABLE 332. EUROPE, MIDDLE EAST & AFRICA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY THERAPEUTIC, 2025-2030 (USD MILLION)
TABLE 333. EUROPE, MIDDLE EAST & AFRICA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 334. EUROPE, MIDDLE EAST & AFRICA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 33
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY KITS & REAGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY KITS & REAGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY DETECTION KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY DETECTION KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY LABELING KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY LABELING KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY KITS & REAGENTS, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY KITS & REAGENTS, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY MHC MOLECULES, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY MHC MOLECULES, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY RECOMBINANT MHC, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY RECOMBINANT MHC, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY SOLUBLE MHC, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY SOLUBLE MHC, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY MHC MOLECULES, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY MHC MOLECULES, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY PEPTIDES, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY PEPTIDES, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY EPITOPE PEPTIDES, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY EPITOPE PEPTIDES, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY MODIFIED PEPTIDES, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY MODIFIED PEPTIDES, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY PEPTIDES, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY PEPTIDES, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY DIAGNOSTIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY DIAGNOSTIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY AUTOIMMUNE DISEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY AUTOIMMUNE DISEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY CANCER DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY CANCER DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY INFECTIOUS DISEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY INFECTIOUS DISEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY DIAGNOSTIC, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY DIAGNOSTIC, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY RESEARCH USE, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY RESEARCH USE, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY BASIC RESEARCH, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY BASIC RESEARCH, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY TRANSLATIONAL RESEARCH, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY TRANSLATIONAL RESEARCH, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY RESEARCH USE, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY RESEARCH USE, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY THERAPEUTIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY THERAPEUTIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY IMMUNOTHERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY IMMUNOTHERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY VACCINE DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY VACCINE DEVELOPMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY THERAPEUTIC, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY THERAPEUTIC, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY HOSPITALS AND DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY HOSPITALS AND DIAGNOSTIC LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY PHARMACEUTICAL BIOTECH COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY PHARMACEUTICAL BIOTECH COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY ELISA, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY ELISA, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY COMPETITIVE ELISA, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY COMPETITIVE ELISA, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY SANDWICH ELISA, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY SANDWICH ELISA, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY ELISA, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY ELISA, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY IMAGING CYTOMETRY, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY IMAGING CYTOMETRY, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY MULTICOLOR CYTOMETRY, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY MULTICOLOR CYTOMETRY, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY FLOW CYTOMETRY, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY FLOW CYTOMETRY, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY LC-MS, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY LC-MS, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY MALDI-TOF, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY MALDI-TOF, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY MASS SPECTROMETRY, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY MHC CLASS, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY MHC CLASS, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY CLASS I, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY CLASS I, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY CLASSICAL CLASS I, BY REGION, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY CLASSICAL CLASS I, BY REGION, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY NON-CLASSICAL CLASS I, BY REGION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY NON-CLASSICAL CLASS I, BY REGION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY CLASS I, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY CLASS I, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY CLASS II, BY REGION, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY CLASS II, BY REGION, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY HLA-DP, BY REGION, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY HLA-DP, BY REGION, 2025-2030 (USD MILLION)
TABLE 113. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY HLA-DQ, BY REGION, 2018-2024 (USD MILLION)
TABLE 114. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY HLA-DQ, BY REGION, 2025-2030 (USD MILLION)
TABLE 115. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY HLA-DR, BY REGION, 2018-2024 (USD MILLION)
TABLE 116. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY HLA-DR, BY REGION, 2025-2030 (USD MILLION)
TABLE 117. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY CLASS II, 2018-2024 (USD MILLION)
TABLE 118. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY CLASS II, 2025-2030 (USD MILLION)
TABLE 119. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY NON-CLASSICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 120. GLOBAL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY NON-CLASSICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 121. AMERICAS MHC-PEPTIDE COMPLEXES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 122. AMERICAS MHC-PEPTIDE COMPLEXES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 123. AMERICAS MHC-PEPTIDE COMPLEXES MARKET SIZE, BY KITS & REAGENTS, 2018-2024 (USD MILLION)
TABLE 124. AMERICAS MHC-PEPTIDE COMPLEXES MARKET SIZE, BY KITS & REAGENTS, 2025-2030 (USD MILLION)
TABLE 125. AMERICAS MHC-PEPTIDE COMPLEXES MARKET SIZE, BY MHC MOLECULES, 2018-2024 (USD MILLION)
TABLE 126. AMERICAS MHC-PEPTIDE COMPLEXES MARKET SIZE, BY MHC MOLECULES, 2025-2030 (USD MILLION)
TABLE 127. AMERICAS MHC-PEPTIDE COMPLEXES MARKET SIZE, BY PEPTIDES, 2018-2024 (USD MILLION)
TABLE 128. AMERICAS MHC-PEPTIDE COMPLEXES MARKET SIZE, BY PEPTIDES, 2025-2030 (USD MILLION)
TABLE 129. AMERICAS MHC-PEPTIDE COMPLEXES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 130. AMERICAS MHC-PEPTIDE COMPLEXES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 131. AMERICAS MHC-PEPTIDE COMPLEXES MARKET SIZE, BY DIAGNOSTIC, 2018-2024 (USD MILLION)
TABLE 132. AMERICAS MHC-PEPTIDE COMPLEXES MARKET SIZE, BY DIAGNOSTIC, 2025-2030 (USD MILLION)
TABLE 133. AMERICAS MHC-PEPTIDE COMPLEXES MARKET SIZE, BY RESEARCH USE, 2018-2024 (USD MILLION)
TABLE 134. AMERICAS MHC-PEPTIDE COMPLEXES MARKET SIZE, BY RESEARCH USE, 2025-2030 (USD MILLION)
TABLE 135. AMERICAS MHC-PEPTIDE COMPLEXES MARKET SIZE, BY THERAPEUTIC, 2018-2024 (USD MILLION)
TABLE 136. AMERICAS MHC-PEPTIDE COMPLEXES MARKET SIZE, BY THERAPEUTIC, 2025-2030 (USD MILLION)
TABLE 137. AMERICAS MHC-PEPTIDE COMPLEXES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 138. AMERICAS MHC-PEPTIDE COMPLEXES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 139. AMERICAS MHC-PEPTIDE COMPLEXES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 140. AMERICAS MHC-PEPTIDE COMPLEXES MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 141. AMERICAS MHC-PEPTIDE COMPLEXES MARKET SIZE, BY ELISA, 2018-2024 (USD MILLION)
TABLE 142. AMERICAS MHC-PEPTIDE COMPLEXES MARKET SIZE, BY ELISA, 2025-2030 (USD MILLION)
TABLE 143. AMERICAS MHC-PEPTIDE COMPLEXES MARKET SIZE, BY FLOW CYTOMETRY, 2018-2024 (USD MILLION)
TABLE 144. AMERICAS MHC-PEPTIDE COMPLEXES MARKET SIZE, BY FLOW CYTOMETRY, 2025-2030 (USD MILLION)
TABLE 145. AMERICAS MHC-PEPTIDE COMPLEXES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2024 (USD MILLION)
TABLE 146. AMERICAS MHC-PEPTIDE COMPLEXES MARKET SIZE, BY MASS SPECTROMETRY, 2025-2030 (USD MILLION)
TABLE 147. AMERICAS MHC-PEPTIDE COMPLEXES MARKET SIZE, BY MHC CLASS, 2018-2024 (USD MILLION)
TABLE 148. AMERICAS MHC-PEPTIDE COMPLEXES MARKET SIZE, BY MHC CLASS, 2025-2030 (USD MILLION)
TABLE 149. AMERICAS MHC-PEPTIDE COMPLEXES MARKET SIZE, BY CLASS I, 2018-2024 (USD MILLION)
TABLE 150. AMERICAS MHC-PEPTIDE COMPLEXES MARKET SIZE, BY CLASS I, 2025-2030 (USD MILLION)
TABLE 151. AMERICAS MHC-PEPTIDE COMPLEXES MARKET SIZE, BY CLASS II, 2018-2024 (USD MILLION)
TABLE 152. AMERICAS MHC-PEPTIDE COMPLEXES MARKET SIZE, BY CLASS II, 2025-2030 (USD MILLION)
TABLE 153. AMERICAS MHC-PEPTIDE COMPLEXES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 154. AMERICAS MHC-PEPTIDE COMPLEXES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 155. UNITED STATES MHC-PEPTIDE COMPLEXES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 156. UNITED STATES MHC-PEPTIDE COMPLEXES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 157. UNITED STATES MHC-PEPTIDE COMPLEXES MARKET SIZE, BY KITS & REAGENTS, 2018-2024 (USD MILLION)
TABLE 158. UNITED STATES MHC-PEPTIDE COMPLEXES MARKET SIZE, BY KITS & REAGENTS, 2025-2030 (USD MILLION)
TABLE 159. UNITED STATES MHC-PEPTIDE COMPLEXES MARKET SIZE, BY MHC MOLECULES, 2018-2024 (USD MILLION)
TABLE 160. UNITED STATES MHC-PEPTIDE COMPLEXES MARKET SIZE, BY MHC MOLECULES, 2025-2030 (USD MILLION)
TABLE 161. UNITED STATES MHC-PEPTIDE COMPLEXES MARKET SIZE, BY PEPTIDES, 2018-2024 (USD MILLION)
TABLE 162. UNITED STATES MHC-PEPTIDE COMPLEXES MARKET SIZE, BY PEPTIDES, 2025-2030 (USD MILLION)
TABLE 163. UNITED STATES MHC-PEPTIDE COMPLEXES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 164. UNITED STATES MHC-PEPTIDE COMPLEXES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 165. UNITED STATES MHC-PEPTIDE COMPLEXES MARKET SIZE, BY DIAGNOSTIC, 2018-2024 (USD MILLION)
TABLE 166. UNITED STATES MHC-PEPTIDE COMPLEXES MARKET SIZE, BY DIAGNOSTIC, 2025-2030 (USD MILLION)
TABLE 167. UNITED STATES MHC-PEPTIDE COMPLEXES MARKET SIZE, BY RESEARCH USE, 2018-2024 (USD MILLION)
TABLE 168. UNITED STATES MHC-PEPTIDE COMPLEXES MARKET SIZE, BY RESEARCH USE, 2025-2030 (USD MILLION)
TABLE 169. UNITED STATES MHC-PEPTIDE COMPLEXES MARKET SIZE, BY THERAPEUTIC, 2018-2024 (USD MILLION)
TABLE 170. UNITED STATES MHC-PEPTIDE COMPLEXES MARKET SIZE, BY THERAPEUTIC, 2025-2030 (USD MILLION)
TABLE 171. UNITED STATES MHC-PEPTIDE COMPLEXES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 172. UNITED STATES MHC-PEPTIDE COMPLEXES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 173. UNITED STATES MHC-PEPTIDE COMPLEXES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 174. UNITED STATES MHC-PEPTIDE COMPLEXES MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 175. UNITED STATES MHC-PEPTIDE COMPLEXES MARKET SIZE, BY ELISA, 2018-2024 (USD MILLION)
TABLE 176. UNITED STATES MHC-PEPTIDE COMPLEXES MARKET SIZE, BY ELISA, 2025-2030 (USD MILLION)
TABLE 177. UNITED STATES MHC-PEPTIDE COMPLEXES MARKET SIZE, BY FLOW CYTOMETRY, 2018-2024 (USD MILLION)
TABLE 178. UNITED STATES MHC-PEPTIDE COMPLEXES MARKET SIZE, BY FLOW CYTOMETRY, 2025-2030 (USD MILLION)
TABLE 179. UNITED STATES MHC-PEPTIDE COMPLEXES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2024 (USD MILLION)
TABLE 180. UNITED STATES MHC-PEPTIDE COMPLEXES MARKET SIZE, BY MASS SPECTROMETRY, 2025-2030 (USD MILLION)
TABLE 181. UNITED STATES MHC-PEPTIDE COMPLEXES MARKET SIZE, BY MHC CLASS, 2018-2024 (USD MILLION)
TABLE 182. UNITED STATES MHC-PEPTIDE COMPLEXES MARKET SIZE, BY MHC CLASS, 2025-2030 (USD MILLION)
TABLE 183. UNITED STATES MHC-PEPTIDE COMPLEXES MARKET SIZE, BY CLASS I, 2018-2024 (USD MILLION)
TABLE 184. UNITED STATES MHC-PEPTIDE COMPLEXES MARKET SIZE, BY CLASS I, 2025-2030 (USD MILLION)
TABLE 185. UNITED STATES MHC-PEPTIDE COMPLEXES MARKET SIZE, BY CLASS II, 2018-2024 (USD MILLION)
TABLE 186. UNITED STATES MHC-PEPTIDE COMPLEXES MARKET SIZE, BY CLASS II, 2025-2030 (USD MILLION)
TABLE 187. UNITED STATES MHC-PEPTIDE COMPLEXES MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 188. UNITED STATES MHC-PEPTIDE COMPLEXES MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 189. CANADA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 190. CANADA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 191. CANADA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY KITS & REAGENTS, 2018-2024 (USD MILLION)
TABLE 192. CANADA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY KITS & REAGENTS, 2025-2030 (USD MILLION)
TABLE 193. CANADA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY MHC MOLECULES, 2018-2024 (USD MILLION)
TABLE 194. CANADA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY MHC MOLECULES, 2025-2030 (USD MILLION)
TABLE 195. CANADA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY PEPTIDES, 2018-2024 (USD MILLION)
TABLE 196. CANADA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY PEPTIDES, 2025-2030 (USD MILLION)
TABLE 197. CANADA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 198. CANADA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 199. CANADA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY DIAGNOSTIC, 2018-2024 (USD MILLION)
TABLE 200. CANADA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY DIAGNOSTIC, 2025-2030 (USD MILLION)
TABLE 201. CANADA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY RESEARCH USE, 2018-2024 (USD MILLION)
TABLE 202. CANADA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY RESEARCH USE, 2025-2030 (USD MILLION)
TABLE 203. CANADA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY THERAPEUTIC, 2018-2024 (USD MILLION)
TABLE 204. CANADA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY THERAPEUTIC, 2025-2030 (USD MILLION)
TABLE 205. CANADA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 206. CANADA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 207. CANADA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 208. CANADA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 209. CANADA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY ELISA, 2018-2024 (USD MILLION)
TABLE 210. CANADA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY ELISA, 2025-2030 (USD MILLION)
TABLE 211. CANADA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY FLOW CYTOMETRY, 2018-2024 (USD MILLION)
TABLE 212. CANADA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY FLOW CYTOMETRY, 2025-2030 (USD MILLION)
TABLE 213. CANADA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2024 (USD MILLION)
TABLE 214. CANADA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY MASS SPECTROMETRY, 2025-2030 (USD MILLION)
TABLE 215. CANADA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY MHC CLASS, 2018-2024 (USD MILLION)
TABLE 216. CANADA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY MHC CLASS, 2025-2030 (USD MILLION)
TABLE 217. CANADA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY CLASS I, 2018-2024 (USD MILLION)
TABLE 218. CANADA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY CLASS I, 2025-2030 (USD MILLION)
TABLE 219. CANADA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY CLASS II, 2018-2024 (USD MILLION)
TABLE 220. CANADA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY CLASS II, 2025-2030 (USD MILLION)
TABLE 221. MEXICO MHC-PEPTIDE COMPLEXES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 222. MEXICO MHC-PEPTIDE COMPLEXES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 223. MEXICO MHC-PEPTIDE COMPLEXES MARKET SIZE, BY KITS & REAGENTS, 2018-2024 (USD MILLION)
TABLE 224. MEXICO MHC-PEPTIDE COMPLEXES MARKET SIZE, BY KITS & REAGENTS, 2025-2030 (USD MILLION)
TABLE 225. MEXICO MHC-PEPTIDE COMPLEXES MARKET SIZE, BY MHC MOLECULES, 2018-2024 (USD MILLION)
TABLE 226. MEXICO MHC-PEPTIDE COMPLEXES MARKET SIZE, BY MHC MOLECULES, 2025-2030 (USD MILLION)
TABLE 227. MEXICO MHC-PEPTIDE COMPLEXES MARKET SIZE, BY PEPTIDES, 2018-2024 (USD MILLION)
TABLE 228. MEXICO MHC-PEPTIDE COMPLEXES MARKET SIZE, BY PEPTIDES, 2025-2030 (USD MILLION)
TABLE 229. MEXICO MHC-PEPTIDE COMPLEXES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 230. MEXICO MHC-PEPTIDE COMPLEXES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 231. MEXICO MHC-PEPTIDE COMPLEXES MARKET SIZE, BY DIAGNOSTIC, 2018-2024 (USD MILLION)
TABLE 232. MEXICO MHC-PEPTIDE COMPLEXES MARKET SIZE, BY DIAGNOSTIC, 2025-2030 (USD MILLION)
TABLE 233. MEXICO MHC-PEPTIDE COMPLEXES MARKET SIZE, BY RESEARCH USE, 2018-2024 (USD MILLION)
TABLE 234. MEXICO MHC-PEPTIDE COMPLEXES MARKET SIZE, BY RESEARCH USE, 2025-2030 (USD MILLION)
TABLE 235. MEXICO MHC-PEPTIDE COMPLEXES MARKET SIZE, BY THERAPEUTIC, 2018-2024 (USD MILLION)
TABLE 236. MEXICO MHC-PEPTIDE COMPLEXES MARKET SIZE, BY THERAPEUTIC, 2025-2030 (USD MILLION)
TABLE 237. MEXICO MHC-PEPTIDE COMPLEXES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 238. MEXICO MHC-PEPTIDE COMPLEXES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 239. MEXICO MHC-PEPTIDE COMPLEXES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 240. MEXICO MHC-PEPTIDE COMPLEXES MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 241. MEXICO MHC-PEPTIDE COMPLEXES MARKET SIZE, BY ELISA, 2018-2024 (USD MILLION)
TABLE 242. MEXICO MHC-PEPTIDE COMPLEXES MARKET SIZE, BY ELISA, 2025-2030 (USD MILLION)
TABLE 243. MEXICO MHC-PEPTIDE COMPLEXES MARKET SIZE, BY FLOW CYTOMETRY, 2018-2024 (USD MILLION)
TABLE 244. MEXICO MHC-PEPTIDE COMPLEXES MARKET SIZE, BY FLOW CYTOMETRY, 2025-2030 (USD MILLION)
TABLE 245. MEXICO MHC-PEPTIDE COMPLEXES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2024 (USD MILLION)
TABLE 246. MEXICO MHC-PEPTIDE COMPLEXES MARKET SIZE, BY MASS SPECTROMETRY, 2025-2030 (USD MILLION)
TABLE 247. MEXICO MHC-PEPTIDE COMPLEXES MARKET SIZE, BY MHC CLASS, 2018-2024 (USD MILLION)
TABLE 248. MEXICO MHC-PEPTIDE COMPLEXES MARKET SIZE, BY MHC CLASS, 2025-2030 (USD MILLION)
TABLE 249. MEXICO MHC-PEPTIDE COMPLEXES MARKET SIZE, BY CLASS I, 2018-2024 (USD MILLION)
TABLE 250. MEXICO MHC-PEPTIDE COMPLEXES MARKET SIZE, BY CLASS I, 2025-2030 (USD MILLION)
TABLE 251. MEXICO MHC-PEPTIDE COMPLEXES MARKET SIZE, BY CLASS II, 2018-2024 (USD MILLION)
TABLE 252. MEXICO MHC-PEPTIDE COMPLEXES MARKET SIZE, BY CLASS II, 2025-2030 (USD MILLION)
TABLE 253. BRAZIL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 254. BRAZIL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 255. BRAZIL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY KITS & REAGENTS, 2018-2024 (USD MILLION)
TABLE 256. BRAZIL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY KITS & REAGENTS, 2025-2030 (USD MILLION)
TABLE 257. BRAZIL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY MHC MOLECULES, 2018-2024 (USD MILLION)
TABLE 258. BRAZIL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY MHC MOLECULES, 2025-2030 (USD MILLION)
TABLE 259. BRAZIL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY PEPTIDES, 2018-2024 (USD MILLION)
TABLE 260. BRAZIL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY PEPTIDES, 2025-2030 (USD MILLION)
TABLE 261. BRAZIL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 262. BRAZIL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 263. BRAZIL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY DIAGNOSTIC, 2018-2024 (USD MILLION)
TABLE 264. BRAZIL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY DIAGNOSTIC, 2025-2030 (USD MILLION)
TABLE 265. BRAZIL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY RESEARCH USE, 2018-2024 (USD MILLION)
TABLE 266. BRAZIL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY RESEARCH USE, 2025-2030 (USD MILLION)
TABLE 267. BRAZIL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY THERAPEUTIC, 2018-2024 (USD MILLION)
TABLE 268. BRAZIL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY THERAPEUTIC, 2025-2030 (USD MILLION)
TABLE 269. BRAZIL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 270. BRAZIL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 271. BRAZIL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 272. BRAZIL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 273. BRAZIL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY ELISA, 2018-2024 (USD MILLION)
TABLE 274. BRAZIL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY ELISA, 2025-2030 (USD MILLION)
TABLE 275. BRAZIL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY FLOW CYTOMETRY, 2018-2024 (USD MILLION)
TABLE 276. BRAZIL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY FLOW CYTOMETRY, 2025-2030 (USD MILLION)
TABLE 277. BRAZIL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2024 (USD MILLION)
TABLE 278. BRAZIL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY MASS SPECTROMETRY, 2025-2030 (USD MILLION)
TABLE 279. BRAZIL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY MHC CLASS, 2018-2024 (USD MILLION)
TABLE 280. BRAZIL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY MHC CLASS, 2025-2030 (USD MILLION)
TABLE 281. BRAZIL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY CLASS I, 2018-2024 (USD MILLION)
TABLE 282. BRAZIL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY CLASS I, 2025-2030 (USD MILLION)
TABLE 283. BRAZIL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY CLASS II, 2018-2024 (USD MILLION)
TABLE 284. BRAZIL MHC-PEPTIDE COMPLEXES MARKET SIZE, BY CLASS II, 2025-2030 (USD MILLION)
TABLE 285. ARGENTINA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 286. ARGENTINA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 287. ARGENTINA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY KITS & REAGENTS, 2018-2024 (USD MILLION)
TABLE 288. ARGENTINA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY KITS & REAGENTS, 2025-2030 (USD MILLION)
TABLE 289. ARGENTINA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY MHC MOLECULES, 2018-2024 (USD MILLION)
TABLE 290. ARGENTINA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY MHC MOLECULES, 2025-2030 (USD MILLION)
TABLE 291. ARGENTINA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY PEPTIDES, 2018-2024 (USD MILLION)
TABLE 292. ARGENTINA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY PEPTIDES, 2025-2030 (USD MILLION)
TABLE 293. ARGENTINA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 294. ARGENTINA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 295. ARGENTINA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY DIAGNOSTIC, 2018-2024 (USD MILLION)
TABLE 296. ARGENTINA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY DIAGNOSTIC, 2025-2030 (USD MILLION)
TABLE 297. ARGENTINA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY RESEARCH USE, 2018-2024 (USD MILLION)
TABLE 298. ARGENTINA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY RESEARCH USE, 2025-2030 (USD MILLION)
TABLE 299. ARGENTINA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY THERAPEUTIC, 2018-2024 (USD MILLION)
TABLE 300. ARGENTINA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY THERAPEUTIC, 2025-2030 (USD MILLION)
TABLE 301. ARGENTINA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 302. ARGENTINA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 303. ARGENTINA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 304. ARGENTINA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 305. ARGENTINA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY ELISA, 2018-2024 (USD MILLION)
TABLE 306. ARGENTINA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY ELISA, 2025-2030 (USD MILLION)
TABLE 307. ARGENTINA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY FLOW CYTOMETRY, 2018-2024 (USD MILLION)
TABLE 308. ARGENTINA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY FLOW CYTOMETRY, 2025-2030 (USD MILLION)
TABLE 309. ARGENTINA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2024 (USD MILLION)
TABLE 310. ARGENTINA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY MASS SPECTROMETRY, 2025-2030 (USD MILLION)
TABLE 311. ARGENTINA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY MHC CLASS, 2018-2024 (USD MILLION)
TABLE 312. ARGENTINA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY MHC CLASS, 2025-2030 (USD MILLION)
TABLE 313. ARGENTINA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY CLASS I, 2018-2024 (USD MILLION)
TABLE 314. ARGENTINA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY CLASS I, 2025-2030 (USD MILLION)
TABLE 315. ARGENTINA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY CLASS II, 2018-2024 (USD MILLION)
TABLE 316. ARGENTINA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY CLASS II, 2025-2030 (USD MILLION)
TABLE 317. EUROPE, MIDDLE EAST & AFRICA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 318. EUROPE, MIDDLE EAST & AFRICA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 319. EUROPE, MIDDLE EAST & AFRICA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY KITS & REAGENTS, 2018-2024 (USD MILLION)
TABLE 320. EUROPE, MIDDLE EAST & AFRICA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY KITS & REAGENTS, 2025-2030 (USD MILLION)
TABLE 321. EUROPE, MIDDLE EAST & AFRICA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY MHC MOLECULES, 2018-2024 (USD MILLION)
TABLE 322. EUROPE, MIDDLE EAST & AFRICA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY MHC MOLECULES, 2025-2030 (USD MILLION)
TABLE 323. EUROPE, MIDDLE EAST & AFRICA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY PEPTIDES, 2018-2024 (USD MILLION)
TABLE 324. EUROPE, MIDDLE EAST & AFRICA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY PEPTIDES, 2025-2030 (USD MILLION)
TABLE 325. EUROPE, MIDDLE EAST & AFRICA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 326. EUROPE, MIDDLE EAST & AFRICA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 327. EUROPE, MIDDLE EAST & AFRICA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY DIAGNOSTIC, 2018-2024 (USD MILLION)
TABLE 328. EUROPE, MIDDLE EAST & AFRICA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY DIAGNOSTIC, 2025-2030 (USD MILLION)
TABLE 329. EUROPE, MIDDLE EAST & AFRICA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY RESEARCH USE, 2018-2024 (USD MILLION)
TABLE 330. EUROPE, MIDDLE EAST & AFRICA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY RESEARCH USE, 2025-2030 (USD MILLION)
TABLE 331. EUROPE, MIDDLE EAST & AFRICA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY THERAPEUTIC, 2018-2024 (USD MILLION)
TABLE 332. EUROPE, MIDDLE EAST & AFRICA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY THERAPEUTIC, 2025-2030 (USD MILLION)
TABLE 333. EUROPE, MIDDLE EAST & AFRICA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 334. EUROPE, MIDDLE EAST & AFRICA MHC-PEPTIDE COMPLEXES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 33
Samples
LOADING...
Companies Mentioned
The companies profiled in this MHC-peptide Complexes market report include:- Thermo Fisher Scientific Inc.
- Merck KGaA
- Danaher Corporation
- Becton Dickinson and Company
- Roche Holding AG
- Bio-Techne Corporation
- Abcam plc
- Enzo Biochem, Inc.
